Nanosuspension coated multiparticulates for controlled delivery of albendazole.

Objective: Improving solubility and bioavailability of albendazole (ALB).

Significance: ALB is a broad-spectrum anthelminthic BCS class II drug with aqueous solubility of solubility of 4.1 mg/l at 25 °C and oral bioavailability of <5%.